Manulife (Manufacturers Life Insurance)
LGND icon

Manulife (Manufacturers Life Insurance)’s Ligand Pharmaceuticals LGND Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Sell
8,909
-202
-2% -$40K ﹤0.01% 1540
2025
Q4 		$1.72M Sell
9,111
-440
-5% -$84.5K ﹤0.01% 1588
2025
Q3 		$1.69M Sell
9,551
-470
-5% -$69.9K ﹤0.01% 1588
2025
Q2 		$1.14M Buy
10,021
+252
+3% +$26.9K ﹤0.01% 1762
2025
Q1 		$1.03M Buy
9,769
+396
+4% +$44.8K ﹤0.01% 1801
2024
Q4 		$1M Buy
9,373
+779
+9% +$88.1K ﹤0.01% 1904
2024
Q3 		$860K Sell
8,594
-167
-2% -$16.8K ﹤0.01% 1998
2024
Q2 		$738K Buy
8,761
+407
+5% +$32.4K ﹤0.01% 2017
2024
Q1 		$611K Buy
8,354
+90
+1% +$6.63K ﹤0.01% 2117
2023
Q4 		$590K Sell
8,264
-278
-3% -$16.4K ﹤0.01% 2104
2023
Q3 		$512K Buy
8,542
+1,759
+26% +$116K ﹤0.01% 2126
2023
Q2 		$489K Buy
6,783
+614
+10% +$46.1K ﹤0.01% 2047
2023
Q1 		$454K Buy
6,169
+31
+0.5% +$2.2K ﹤0.01% 2068
2022
Q4 		$410K Sell
6,138
-3,536
-37% -$230K ﹤0.01% 2114
2022
Q3 		$520K Sell
9,674
-152
-2% -$8.94K ﹤0.01% 1957
2022
Q2 		$547K Sell
9,826
-201
-2% -$11.4K ﹤0.01% 1994
2022
Q1 		$704K Sell
10,027
-2,242
-18% -$163K ﹤0.01% 1965
2021
Q4 		$1.18K Sell
12,269
-401
-3% -$37K ﹤0.01% 1732
2021
Q3 		$1.1M Sell
12,670
-29,676
-70% -$2.3M ﹤0.01% 1780
2021
Q2 		$3.47M Sell
42,346
-89
-0.2% -$7.4K ﹤0.01% 1420
2021
Q1 		$4.04M Sell
42,435
-208,128
-83% -$19.7M ﹤0.01% 1346
2020
Q4 		$15.5M Buy
250,563
+41,115
+20% +$2.34M 0.01% 698
2020
Q3 		$12.5M Buy
209,448
+9,935
+5% +$678K 0.01% 708
2020
Q2 		$14.1M Sell
199,513
-8,074
-4% -$512K 0.01% 647
2020
Q1 		$9.42M Sell
207,587
-411,702
-66% -$23.3M 0.01% 742
2019
Q4 		$40.3M Sell
619,289
-428
-0.1% -$28.6K 0.04% 367
2019
Q3 		$38.3M Sell
619,717
-117,172
-16% -$7.36M 0.04% 384
2019
Q2 		$52.5M Sell
736,889
-156,803
-18% -$11.5M 0.06% 292
2019
Q1 		$70.1M Buy
893,692
+244,697
+38% +$18.5M 0.08% 242
2018
Q4 		$54.9M Buy
648,995
+103,233
+19% +$11M 0.07% 271
2018
Q3 		$93.5M Sell
545,762
-3,056
-0.6% -$461K 0.1% 205
2018
Q2 		$70.9M Buy
548,818
+524,526
+2,159% +$58.5M 0.08% 255
2018
Q1 		$2.5M Sell
24,292
-696
-3% -$68.8K ﹤0.01% 1423
2017
Q4 		$2.13M Buy
24,988
+255
+1% +$22.1K ﹤0.01% 1461
2017
Q3 		$2.1M Sell
24,733
-322
-1% -$25.5K ﹤0.01% 1414
2017
Q2 		$1.9M Buy
25,055
+1,436
+6% +$100K ﹤0.01% 1475
2017
Q1 		$1.56M Buy
23,619
+2,830
+14% +$186K ﹤0.01% 1524
2016
Q4 		$1.32M Buy
20,789
+57
+0.3% +$3.6K ﹤0.01% 1545
2016
Q3 		$1.32M Buy
20,732
+138
+0.7% +$10.1K ﹤0.01% 1512
2016
Q2 		$1.53M Buy
20,594
+1,889
+10% +$140K ﹤0.01% 1424
2016
Q1 		$1.23M Buy
18,705
+344
+2% +$20.9K ﹤0.01% 1528
2015
Q4 		$1.24K Buy
18,361
+175
+1% +$10.8K ﹤0.01% 1522
2015
Q3 		$972 Buy
18,186
+497
+3% +$30.2K ﹤0.01% 1615
2015
Q2 		$1.11K Sell
17,689
-3,233
-15% -$176K ﹤0.01% 1629
2015
Q1 		$1.01K Buy
20,922
+170
+0.8% +$6.51K ﹤0.01% 1680
2014
Q4 		$688 Sell
20,752
-889
-4% -$28.9K ﹤0.01% 1806
2014
Q3 		$634 Sell
21,641
-75,576
-78% -$2.51M ﹤0.01% 1840
2014
Q2 		$3.78M Buy
97,217
+75,488
+347% +$3.06M 0.01% 1136
2014
Q1 		$911 Sell
21,729
-136
-0.6% -$5.67K ﹤0.01% 1686
2013
Q4 		$717 Sell
21,865
-152
-0.7% -$4.95K ﹤0.01% 1819
2013
Q3 		$594 Sell
22,017
-215
-1% -$6.05K ﹤0.01% 1885
2013
Q2 		$519K Buy
+22,232
New +$400K ﹤0.01% 1868

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LGND Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Ligand Pharmaceuticals (LGND) stake by 2.2% in Q1 2026, selling an estimated $40K and leaving 8,909 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Manulife (Manufacturers Life Insurance) first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $93.5M in Q3 2018. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 8,909 shares of Ligand Pharmaceuticals worth $1.78M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 202 Ligand Pharmaceuticals shares in Q1 2026, an estimated $40K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1540 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Ligand Pharmaceuticals position peaked at $93.5M in Q3 2018.
  • 358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.